One Platform to Help You Shift to Value-Based Care

HealthViewX Healthcare Orchestration Technology Platform

We help healthcare providers orchestrate care continuum pathways and enhance the experience of patients, providers, and communities.

Your Care Pathways, The Patient’s Way!

Learn More Schedule A Demo
HealthViewX Healthcare Orchestration Technology Platform

HealthViewX Platform Statistics*

We continue to add value to the healthcare community by orchestrating care pathways and touching more lives.

Hope Platform
  • 2,734,045

  • 758,291

  • 1,358,865

  • 425,731

  • 14,782

  • 808

  • 48

  • 275,001

Hope Platform
  • 823,229

  • 120,679

  • 86

Hope Platform
  • 589,248

  • 1,009,050

  • 3,290

* Updated on March 18th 2024

Value-based Care Application Suite for Healthcare

Why Should You Choose HealthViewX

HealthViewX leverages its patented Healthcare Orchestration Platform to seamlessly align and personalize the experience of the patient, provider, and community. A seamless way to deliver Value-based Care!

HealthViewX - Healthcare Digital Transformation Partner for Delivering Value based care
  • HIPAA and GDPR Compliant Software

    HIPAA & GDPR Compliant

    Continued compliance with HIPAA & GDPR data privacy standards

  • HITRUST CSF Compliant Software

    HITRUST CSF Certified

    Hosted in a HITRUST CSF Certified environment

  • Web-based Healthcare Apps

    Cloud-based Apps

    Accessible over a secure cloud network allowing scalability

  • User Friendly Health App

    User Friendly

    Simple & intuitive interface for enhanced user experience

  • Actionable-Insights for Healthcare

    Actionable Insights

    Advanced dashboard & reports for informed decision making

Become a Reseller / Partner / Consultant

HealthViewX is looking to onboard strategic partners who can promote, influence, and sell our Healthcare technology offerings across the globe. Talk to us to know how we can work together to orchestrate a brilliant experience for patients, providers, and communities.